BioGaia AB (publ)
BGLAF
$10.24
-$0.18-1.74%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 34.34M | 41.89M | 34.34M | 33.82M | 29.19M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 34.34M | 41.89M | 34.34M | 33.82M | 29.19M |
| Cost of Revenue | 8.84M | 11.47M | 9.18M | 9.85M | 7.84M |
| Gross Profit | 25.49M | 30.42M | 25.16M | 23.96M | 21.35M |
| SG&A Expenses | 13.32M | 15.56M | 11.64M | 12.38M | 10.06M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 24.88M | 30.18M | 22.95M | 25.37M | 24.75M |
| Operating Income | 9.46M | 11.71M | 11.39M | 8.45M | 4.43M |
| Income Before Tax | 8.97M | 11.43M | 9.55M | 9.69M | 4.51M |
| Income Tax Expenses | 2.04M | 2.33M | 2.04M | 2.09M | 996.60K |
| Earnings from Continuing Operations | 6.93M | 9.10M | 7.52M | 7.59M | 3.51M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 6.93M | 9.10M | 7.52M | 7.59M | 3.51M |
| EBIT | 9.46M | 11.71M | 11.39M | 8.45M | 4.43M |
| EBITDA | 10.10M | 12.35M | 11.97M | 9.12M | 9.96M |
| EPS Basic | 0.07 | 0.09 | 0.07 | 0.08 | 0.03 |
| Normalized Basic EPS | 0.06 | 0.07 | 0.06 | 0.07 | 0.03 |
| EPS Diluted | 0.07 | 0.09 | 0.07 | 0.08 | 0.03 |
| Normalized Diluted EPS | 0.06 | 0.07 | 0.06 | 0.07 | 0.03 |
| Average Basic Shares Outstanding | 101.16M | 101.16M | 101.16M | 101.16M | 101.07M |
| Average Diluted Shares Outstanding | 101.16M | 101.16M | 101.16M | 101.16M | 101.08M |
| Dividend Per Share | -- | -- | -- | 0.18 | -- |
| Payout Ratio | -- | 794.05% | -- | -- | -- |